|
US4444887A
(en)
|
1979-12-10 |
1984-04-24 |
Sloan-Kettering Institute |
Process for making human antibody producing B-lymphocytes
|
|
US5833975A
(en)
|
1989-03-08 |
1998-11-10 |
Virogenetics Corporation |
Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence
|
|
US4603112A
(en)
|
1981-12-24 |
1986-07-29 |
Health Research, Incorporated |
Modified vaccinia virus
|
|
US4722848A
(en)
|
1982-12-08 |
1988-02-02 |
Health Research, Incorporated |
Method for immunizing animals with synthetically modified vaccinia virus
|
|
US5174993A
(en)
|
1981-12-24 |
1992-12-29 |
Health Research Inc. |
Recombinant avipox virus and immunological use thereof
|
|
US5110587A
(en)
|
1981-12-24 |
1992-05-05 |
Health Research, Incorporated |
Immunogenic composition comprising synthetically modified vaccinia virus
|
|
US4769330A
(en)
|
1981-12-24 |
1988-09-06 |
Health Research, Incorporated |
Modified vaccinia virus and methods for making and using the same
|
|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
US4716111A
(en)
|
1982-08-11 |
1987-12-29 |
Trustees Of Boston University |
Process for producing human antibodies
|
|
ZA836080B
(en)
|
1982-08-23 |
1984-04-25 |
Scripps Clinic Res |
Broad spectrum influenza antisera
|
|
US5106619A
(en)
|
1983-12-20 |
1992-04-21 |
Diamond Scientific Co. |
Preparation of inactivated viral vaccines
|
|
US4693981A
(en)
|
1983-12-20 |
1987-09-15 |
Advanced Genetics Research Institute |
Preparation of inactivated viral vaccines
|
|
US5182192A
(en)
|
1987-03-27 |
1993-01-26 |
The Wistar Institute |
Monoclonal antibodies against glycolipid antigens, methods of producing these antibodies, and use therefor
|
|
US5057540A
(en)
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
|
US5413923A
(en)
|
1989-07-25 |
1995-05-09 |
Cell Genesys, Inc. |
Homologous recombination for universal donor cells and chimeric mammalian hosts
|
|
US20060019350A1
(en)
|
1989-08-28 |
2006-01-26 |
Peter Palese |
Recombinant negative strand RNA virus expression system and vacccines
|
|
US5166057A
(en)
|
1989-08-28 |
1992-11-24 |
The Mount Sinai School Of Medicine Of The City University Of New York |
Recombinant negative strand rna virus expression-systems
|
|
US5854037A
(en)
|
1989-08-28 |
1998-12-29 |
The Mount Sinai School Of Medicine Of The City University Of New York |
Recombinant negative strand RNA virus expression systems and vaccines
|
|
US6001634A
(en)
|
1989-08-28 |
1999-12-14 |
Palese; Peter |
Recombinant negative strand RNA viruses
|
|
EP1690934A3
(en)
|
1990-01-12 |
2008-07-30 |
Abgenix, Inc. |
Generation of xenogeneic antibodies
|
|
US6887699B1
(en)
|
1990-05-22 |
2005-05-03 |
Medimmune Vaccines, Inc. |
Recombinant negative strand RNA virus expression systems and vaccines
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
FR2664905B1
(fr)
|
1990-07-18 |
1994-08-12 |
Agronomique Inst Nat Rech |
Baculovirus modifie, son procede d'obtention, et vecteurs d'expression obtenus a partir dudit baculovirus.
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
ATE300615T1
(de)
|
1990-08-29 |
2005-08-15 |
Genpharm Int |
Transgene mäuse fähig zur produktion heterologer antikörper
|
|
US5612487A
(en)
|
1991-08-26 |
1997-03-18 |
Edible Vaccines, Inc. |
Anti-viral vaccines expressed in plants
|
|
US6034298A
(en)
|
1991-08-26 |
2000-03-07 |
Prodigene, Inc. |
Vaccines expressed in plants
|
|
US5484719A
(en)
|
1991-08-26 |
1996-01-16 |
Edible Vaccines, Inc. |
Vaccines produced and administered through edible plants
|
|
ES2341666T3
(es)
|
1991-12-02 |
2010-06-24 |
Medimmune Limited |
Produccion de autoanticuerpos de repertorios de segmentos de anticue rpos expresados en la superficie de fagos.
|
|
US6022726A
(en)
|
1992-02-03 |
2000-02-08 |
Palese; Peter |
Genetically engineered attenuated viruses
|
|
JP3037554B2
(ja)
|
1993-04-20 |
2000-04-24 |
寳酒造株式会社 |
免疫原性人工ポリペプチド
|
|
US5589174A
(en)
|
1992-09-17 |
1996-12-31 |
Takara Shuzo Co., Ltd. |
Anti-human influenza virus antibody
|
|
EP0621339B1
(en)
|
1992-09-17 |
2001-10-24 |
Takara Shuzo Co. Ltd. |
Immunogenic human influenza A virus haemagglutinin polypeptides
|
|
US6337070B1
(en)
|
1993-04-29 |
2002-01-08 |
Takara Shuzo Co., Ltd. |
Polypeptides for use in generating anti-human influenza virus antibodies
|
|
GB9221654D0
(en)
|
1992-10-15 |
1992-11-25 |
Scotgen Ltd |
Recombinant human anti-cytomegalovirus antibodies
|
|
WO1994012629A1
(en)
|
1992-12-02 |
1994-06-09 |
Baylor College Of Medicine |
Episomal vectors for gene therapy
|
|
WO1994016109A1
(en)
|
1993-01-15 |
1994-07-21 |
Whitehead Institute For Biomedical Research |
Membrane fusion events and means for altering same
|
|
WO1994017826A1
(en)
|
1993-02-01 |
1994-08-18 |
Smithkline Beecham Corporation |
Vaccinal polypeptides
|
|
US5573916A
(en)
|
1994-05-19 |
1996-11-12 |
Coretech, Inc. |
Immunogenic constructs comprising b-cell and t-cell epitopes on common carrier
|
|
US5505947A
(en)
|
1994-05-27 |
1996-04-09 |
The University Of North Carolina At Chapel Hill |
Attenuating mutations in Venezuelan Equine Encephalitis virus
|
|
US5622701A
(en)
|
1994-06-14 |
1997-04-22 |
Protein Design Labs, Inc. |
Cross-reacting monoclonal antibodies specific for E- and P-selectin
|
|
PT702085E
(pt)
|
1994-07-18 |
2004-04-30 |
Karl Klaus Conzelmann |
Virus de arn de cadeia negativa nao segmentada infeccioso recombinante
|
|
CA2201592A1
(en)
|
1994-10-03 |
1996-04-18 |
The Government Of The United States Of America, Represented By The Secre Tary, Department Of Health And Human Services |
Enhanced immune response by introduction of cytokine gene and/or costimulatory molecule b7 gene in a recombinant virus expressing system
|
|
CA2219361C
(en)
|
1995-04-27 |
2012-02-28 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
EP0823941A4
(en)
|
1995-04-28 |
2001-09-19 |
Abgenix Inc |
HUMAN ANTIBODIES DERIVED FROM IMMUNIZED XENO MOUSES
|
|
US7153510B1
(en)
|
1995-05-04 |
2006-12-26 |
Yale University |
Recombinant vesiculoviruses and their uses
|
|
ATE181112T1
(de)
|
1995-08-09 |
1999-06-15 |
Schweiz Serum & Impfinst |
Dem genom von minussträngigen rna-viren entsprechende cdna und verfahren zur herstellung von infektiösen minussträngigen rna-viren
|
|
DE69637875D1
(de)
|
1995-09-14 |
2009-04-30 |
Virginia Tech Intell Prop |
Produktion von lysosomalen enzymen in pflanzlichen expressionssystemen
|
|
AU727923B2
(en)
|
1995-09-27 |
2001-01-04 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Production of infectious respiratory syncytial virus from cloned nucleotide sequences
|
|
JP2820106B2
(ja)
|
1996-02-29 |
1998-11-05 |
日本電気株式会社 |
トラヒックシェーパ装置
|
|
JP2000510332A
(ja)
|
1996-04-19 |
2000-08-15 |
ヘンリー エム．ジャクソン ファンデーション フォー ザ アドバンスメント オブ ミリタリー メディシン |
インチミンを単独で、または１以上の他の抗原との融合タンパク質として発現する宿主生物の投与による、免疫応答を刺激する方法
|
|
CA2252438C
(en)
|
1996-04-19 |
2011-03-29 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability
|
|
EP0912724B1
(en)
|
1996-07-15 |
2009-12-09 |
The Government of The United States of America, as represented by The Department of Health and Human Services |
Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences
|
|
US20050032211A1
(en)
|
1996-09-26 |
2005-02-10 |
Metabogal Ltd. |
Cell/tissue culturing device, system and method
|
|
IL155588A0
(en)
|
2003-04-27 |
2003-11-23 |
Metabogal Ltd |
Methods for expression of enzymatically active recombinant lysosomal enzymes in transgenic plant root cells and vectors used thereby
|
|
KR20000048628A
(ko)
|
1996-09-27 |
2000-07-25 |
윌리암 에이취 캘넌, 에곤 이 버그 |
모노네가비랄레스 목의 바이러스에서 감쇠를 책임지는 3' 게놈프로모터 영역 및 폴리머라제 유전자 돌연변이
|
|
US5916771A
(en)
|
1996-10-11 |
1999-06-29 |
Abgenix, Inc. |
Production of a multimeric protein by cell fusion method
|
|
EP1500329B1
(en)
|
1996-12-03 |
2012-03-21 |
Amgen Fremont Inc. |
Human antibodies that specifically bind human TNF alpha
|
|
US5891705A
(en)
|
1997-04-08 |
1999-04-06 |
Pentose Pharmaceuticals, Inc. |
Method for inactivating a virus
|
|
BRPI9809391B8
(pt)
|
1997-04-14 |
2021-05-25 |
Amgen Res Munich Gmbh |
processo para a produção de um receptor de antígeno anti-humano, anticorpo humano e composição farmacêutica
|
|
US6235883B1
(en)
|
1997-05-05 |
2001-05-22 |
Abgenix, Inc. |
Human monoclonal antibodies to epidermal growth factor receptor
|
|
KR100702523B1
(ko)
|
1997-05-23 |
2007-04-04 |
더 가번먼트 오브 더 유나이티드 스테이츠 오브 아메리카, 에즈 레프리젠티드 바이 더 디파트먼트 오브 헬쓰 앤드 휴먼 서비시즈 |
클로닝된 뉴클레오타이드 서열로부터 약독화된파라인플루엔자 바이러스를 제조하는 방법
|
|
US6165476A
(en)
|
1997-07-10 |
2000-12-26 |
Beth Israel Deaconess Medical Center |
Fusion proteins with an immunoglobulin hinge region linker
|
|
PT1012244E
(pt)
|
1997-07-11 |
2007-08-21 |
Univ Yale |
''rabdovírus com revestimentos remanipulados''
|
|
CN1273603A
(zh)
|
1997-09-19 |
2000-11-15 |
美国氰胺公司 |
减毒的呼吸道合胞病毒
|
|
KR100637937B1
(ko)
|
1998-06-12 |
2006-10-23 |
마운트 시나이 스쿨 오브 메디신 오브 뉴욕 유니버시티 |
변형된 인터페론 길항물질을 보유하고, 백신 및 약제로사용되는 약독화된 네거티브 가닥 바이러스
|
|
ATE384126T1
(de)
|
1998-06-12 |
2008-02-15 |
Sinai School Medicine |
Interferon induzierende genetisch veränderte attenuierte viren
|
|
US6544785B1
(en)
|
1998-09-14 |
2003-04-08 |
Mount Sinai School Of Medicine Of New York University |
Helper-free rescue of recombinant negative strand RNA viruses
|
|
US6146642A
(en)
|
1998-09-14 |
2000-11-14 |
Mount Sinai School Of Medicine, Of The City University Of New York |
Recombinant new castle disease virus RNA expression systems and vaccines
|
|
CA2357004A1
(en)
|
1998-12-23 |
2000-06-29 |
Boyce Thompson Institute For Plant Research |
Expression of immunogenic hepatitis b surface antigens in transgenic plants
|
|
AT407958B
(de)
|
1999-02-11 |
2001-07-25 |
Immuno Ag |
Inaktivierte influenza-virus-vakzine zur nasalen oder oralen applikation
|
|
US8715940B2
(en)
|
1999-04-06 |
2014-05-06 |
Wisconsin Alumni Research Foundation |
Method of making recombinant influenza virus
|
|
CA2365592C
(en)
|
1999-04-29 |
2011-11-15 |
Zeneca Limited |
Herbicide resistant plants comprising epsps
|
|
ES2278621T5
(es)
|
1999-07-14 |
2011-02-02 |
Mount Sinai School Of Medicine Of New York University |
Reconstrucción in vitro de virus arn segmentados de polaridad negativa.
|
|
TR200200776T2
(tr)
|
1999-09-24 |
2002-06-21 |
Smithkline Beecham Biologicals S.A. |
Burun içi grip virüsü aşısı.
|
|
US7521220B2
(en)
|
1999-11-26 |
2009-04-21 |
Crucell Holland B.V. |
Production of vaccines
|
|
WO2001071014A2
(en)
|
2000-03-17 |
2001-09-27 |
Boyce Thompson Institute For Plant Research, Inc. |
Expression of recombinant human acetylcholinesterase in transgenic plants
|
|
MXPA02010642A
(es)
|
2000-04-28 |
2004-05-17 |
St Jude Children S Res Hospital |
Sistema de transfeccion de adn para la generacion de virus de influenza infeccioso.
|
|
US6632620B1
(en)
|
2000-06-22 |
2003-10-14 |
Andrew N. Makarovskiy |
Compositions for identification and isolation of stem cells
|
|
JP5008244B2
(ja)
|
2000-06-23 |
2012-08-22 |
ワイス・ホールディングズ・コーポレイション |
野性型およびキメラのインフルエンザウイルス様粒子（ｖｌｐ）のアセンブリー
|
|
JP4188687B2
(ja)
|
2000-12-27 |
2008-11-26 |
ダイナバックス テクノロジーズ コーポレイション |
免疫変調ポリヌクレオチド及びその使用法
|
|
US7132510B2
(en)
|
2000-12-29 |
2006-11-07 |
Bio-Technology General (Israel) Ltd. |
Specific human antibodies for selective cancer therapy
|
|
AU2003219745B8
(en)
|
2002-02-13 |
2008-10-09 |
Wisconsin Alumni Research Foundation |
Signal for packaging of influenza virus vectors
|
|
US20040091503A1
(en)
|
2002-08-20 |
2004-05-13 |
Genitrix, Llc |
Lectin compositions and methods for modulating an immune response to an antigen
|
|
CA2514177A1
(en)
|
2003-01-29 |
2004-08-12 |
Josef Michl |
Tolerance-induced targeted antibody production
|
|
ATE426412T1
(de)
|
2003-01-30 |
2009-04-15 |
Novartis Vaccines & Diagnostic |
Adjuvante influenza-vakzine
|
|
US7695725B2
(en)
|
2003-02-06 |
2010-04-13 |
Aduro Biotech |
Modified free-living microbes, vaccine compositions and methods of use thereof
|
|
JP4368594B2
(ja)
|
2003-02-24 |
2009-11-18 |
株式会社インシリコサイエンス |
タンパク質構造予測装置、タンパク質構造予測方法、プログラム、および、記録媒体
|
|
US7951557B2
(en)
|
2003-04-27 |
2011-05-31 |
Protalix Ltd. |
Human lysosomal proteins from plant cell culture
|
|
ATE473271T1
(de)
|
2003-05-05 |
2010-07-15 |
Thompson Boyce Plant Res |
Vektoren und zellen zur herstellung von aus transgenen pflanzen gewonnenen immunprotektiven zusammensetzungen
|
|
CA2525251C
(en)
|
2003-05-09 |
2015-10-27 |
Duke University |
Cd20-specific antibodies and methods employing same
|
|
US7566458B2
(en)
|
2003-06-16 |
2009-07-28 |
Medimmune, Llc |
Influenza hemagglutinin and neuraminidase variants
|
|
US8551756B2
(en)
*
|
2003-07-11 |
2013-10-08 |
Novavax, Inc. |
Avian influenza chimeric VLPS
|
|
US8592197B2
(en)
|
2003-07-11 |
2013-11-26 |
Novavax, Inc. |
Functional influenza virus-like particles (VLPs)
|
|
DK1692265T3
(da)
|
2003-11-04 |
2011-11-21 |
Univ Tulane |
Fremgangsmåde til hindring af en virus-celle-fusion ved hæmning af fusionsinitieringsområdets funktion i RNA-vira med klasse 1-membranfusogene envelopeproteiner
|
|
CA2879182C
(en)
|
2004-05-25 |
2017-02-14 |
Medimmune, Inc. |
Influenza hemagglutinin and neuraminidase variants
|
|
CA2583691A1
(en)
|
2004-10-13 |
2006-04-20 |
Protalix Ltd. |
System and method for production of antibodies in plant cell culture
|
|
CN101103103A
(zh)
|
2004-11-19 |
2008-01-09 |
威斯康星旧生研究基金会 |
具有串联转录单位的重组流感病毒载体
|
|
WO2006088481A2
(en)
|
2005-02-15 |
2006-08-24 |
Mount Sinai School Of Medicine Of New York University |
Genetically engineered equine influenza virus and uses thereof
|
|
EP1851238A4
(en)
|
2005-02-24 |
2008-12-31 |
Univ Massachusetts |
FLUID NUCLEIC ACIDS, POLYPEPTIDES AND USES THEREOF
|
|
EP2447281B1
(en)
|
2005-03-24 |
2015-12-16 |
ThromboGenics N.V. |
Novel anti-PLGF antibody
|
|
AU2006252406B2
(en)
|
2005-06-01 |
2012-05-17 |
California Institute Of Technology |
Method of targeted gene delivery using viral vectors
|
|
JP4758148B2
(ja)
|
2005-06-14 |
2011-08-24 |
泰三 宇田 |
インフルエンザウイルスのヘマグルチニンに対する抗体酵素
|
|
US7951384B2
(en)
|
2005-08-05 |
2011-05-31 |
University Of Massachusetts |
Virus-like particles as vaccines for paramyxovirus
|
|
NZ568211A
(en)
|
2005-11-04 |
2011-11-25 |
Novartis Vaccines & Diagnostic |
Influenza vaccines including combinations of particulate adjuvants and immunopotentiators
|
|
EP1790664A1
(en)
|
2005-11-24 |
2007-05-30 |
Ganymed Pharmaceuticals AG |
Monoclonal antibodies against claudin-18 for treatment of cancer
|
|
KR101492643B1
(ko)
|
2005-12-02 |
2015-02-12 |
이칸 스쿨 오브 메디슨 엣 마운트 시나이 |
비-천연 표면 단백질을 제시하는 키메라 바이러스 및 그의용도
|
|
WO2007066334A1
(en)
|
2005-12-06 |
2007-06-14 |
Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science |
Improved influenza vaccine
|
|
US10183986B2
(en)
|
2005-12-15 |
2019-01-22 |
Industrial Technology Research Institute |
Trimeric collagen scaffold antibodies
|
|
AU2007215080A1
(en)
|
2006-02-13 |
2007-08-23 |
Fraunhofer Usa, Inc. |
Influenza antigens, vaccine compositions, and related methods
|
|
US20070207171A1
(en)
|
2006-03-01 |
2007-09-06 |
Cerus Corporation |
Engineered listeria and methods of use thereof
|
|
US20070224205A1
(en)
|
2006-03-07 |
2007-09-27 |
Powell Thomas J |
Compositions that include hemagglutinin, methods of making and methods of use thereof
|
|
CA2646539A1
(en)
|
2006-03-23 |
2007-09-27 |
Novartis Ag |
Imidazoquinoxaline compounds as immunomodulators
|
|
CA2646891A1
(en)
|
2006-03-23 |
2007-09-27 |
Novartis Ag |
Immunopotentiating compounds
|
|
EP2004226A1
(en)
|
2006-03-24 |
2008-12-24 |
Novartis Vaccines and Diagnostics GmbH & Co. KG |
Storage of influenza vaccines without refrigeration
|
|
WO2007126810A2
(en)
|
2006-03-31 |
2007-11-08 |
Warf - Wisconsin Alumni Research Foundation |
High titer recombinant influenza viruses for vaccines
|
|
US9101578B2
(en)
|
2006-05-01 |
2015-08-11 |
Technovax, Inc. |
Polyvalent influenza virus-like particle (VLP) compositions
|
|
US20070262178A1
(en)
|
2006-05-12 |
2007-11-15 |
Ultradent Products, Inc. |
Syringe delivery tip including an enlarged flocked wing element adjacent a distal delivery end
|
|
US8148085B2
(en)
|
2006-05-15 |
2012-04-03 |
Sea Lane Biotechnologies, Llc |
Donor specific antibody libraries
|
|
EP2024393A2
(en)
|
2006-05-15 |
2009-02-18 |
Sea Lane Biotechnologies,llc. |
Neutralizing antibodies to influenza viruses
|
|
US9511134B2
(en)
|
2006-05-18 |
2016-12-06 |
Epimmune Inc. |
Inducing immune responses to influenza virus using polypeptide and nucleic acid compositions
|
|
WO2008005777A2
(en)
|
2006-06-30 |
2008-01-10 |
Novavax, Inc. |
Methods of enhancing protein incorporation into virus like particles
|
|
BRPI0714495B8
(pt)
|
2006-07-21 |
2021-05-25 |
California Inst Of Techn |
lentivírus deficiente para replicação recombinante pseudotipado
|
|
JP5161882B2
(ja)
|
2006-09-07 |
2013-03-13 |
クルセル ホランド ベー ヴェー |
インフルエンザウイルスｈ５ｎ１を中和しうるヒト結合性分子およびその使用
|
|
ES2536401T3
(es)
|
2006-09-11 |
2015-05-25 |
Novartis Ag |
Fabricación de vacunas contra virus de la gripe sin usar huevos
|
|
EP2716656B1
(en)
|
2007-06-15 |
2016-10-12 |
Xiamen University |
Monoclonal antibodies binding to avian influenza virus subtype H5 haemagglutinin and uses thereof
|
|
EP2014279A1
(en)
|
2007-06-22 |
2009-01-14 |
Pevion Biotech AG |
Virosomes comprising hemagglutinin derived from an influenza virus produced in a cell line, compositions, methods of manufacturing, use thereof
|
|
EA201070066A1
(ru)
|
2007-06-27 |
2010-06-30 |
Новартис Аг |
Вакцины против гриппа с низким содержанием добавок
|
|
CA2615372A1
(en)
|
2007-07-13 |
2009-01-13 |
Marc-Andre D'aoust |
Influenza virus-like particles (vlps) comprising hemagglutinin
|
|
JP5187883B2
(ja)
|
2007-07-18 |
2013-04-24 |
独立行政法人科学技術振興機構 |
抗原ペプチドおよびその利用
|
|
HUE025702T2
(en)
|
2007-07-19 |
2016-04-28 |
Novavax Inc |
Avian Flu Chimeric VLPs
|
|
WO2009025770A2
(en)
|
2007-08-17 |
2009-02-26 |
Wyeth |
A heterologous prime-boost immunization regimen
|
|
WO2009088401A2
(en)
|
2007-09-24 |
2009-07-16 |
Government Of The Usa, As Represented By The Secretary, Dept. Of Health And Human Services |
Immunostimulatory combinations of tlr ligands and methods of use
|
|
FR2921387B1
(fr)
|
2007-09-26 |
2012-04-20 |
Sanofi Pasteur |
Procede de production du virus de la grippe
|
|
GB0810305D0
(en)
|
2008-06-05 |
2008-07-09 |
Novartis Ag |
Influenza vaccination
|
|
EP2238253B1
(en)
|
2007-11-27 |
2012-09-12 |
Medicago Inc. |
Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin
|
|
EP3524619A1
(en)
|
2007-12-06 |
2019-08-14 |
Dana-Farber Cancer Institute, Inc. |
Antibodies against influenza virus and methods of use thereof
|
|
WO2009092038A1
(en)
|
2008-01-16 |
2009-07-23 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Influenza dna vaccination and methods of use thereof
|
|
ITTO20080204A1
(it)
|
2008-03-17 |
2009-09-18 |
Pomona Biotechnologies Llc |
Anticorpi monoclonali atti a reagire con una pluralita di sottotipi del virus influenzale a
|
|
WO2009121004A2
(en)
|
2008-03-28 |
2009-10-01 |
Sea Lane Biotechnologies, Llc |
Neutralizing molecules to viral antigens
|
|
GB0905570D0
(en)
|
2009-03-31 |
2009-05-13 |
Novartis Ag |
Combined vaccines
|
|
EP2540740B1
(en)
|
2008-06-17 |
2014-09-10 |
Apogenix GmbH |
Multimeric TNF receptors
|
|
PL2300609T3
(pl)
|
2008-06-25 |
2014-05-30 |
Inst Nat Sante Rech Med |
Nowe związki na bazie flageliny o charakterze immunoadiuwantów i ich zastosowanie
|
|
DK2294202T3
(en)
|
2008-07-08 |
2015-08-31 |
Medicago Inc |
SOLUBLE RECOMBINANT INFLUENZA ANTIGENES
|
|
CN102159622A
(zh)
|
2008-09-23 |
2011-08-17 |
聂克斯姆化学有限公司 |
炔属聚酰胺
|
|
US20110177122A1
(en)
|
2008-09-26 |
2011-07-21 |
The United States Of America, As Represented By The Secretary, Dept. Of Health & Human Services |
Dna prime/activated vaccine boost immunization to influenza virus
|
|
CA2756206C
(en)
|
2009-03-27 |
2025-05-13 |
Academia Sinica |
METHODS AND COMPOSITIONS FOR IMMUNIZATION AGAINST A VIRUS
|
|
EP3009145A1
(en)
|
2009-03-30 |
2016-04-20 |
Mount Sinai School of Medicine of New York University |
Influenza virus vaccines and uses thereof
|
|
AU2010247530B2
(en)
|
2009-05-11 |
2016-10-13 |
Janssen Vaccines & Prevention B.V. |
Human binding molecules capable of neutralizing influenza virus H3N2 and uses thereof
|
|
AU2010254136B2
(en)
|
2009-05-26 |
2016-09-29 |
Mount Sinai School Of Medicine |
Monoclonal antibodies against influenza virus generated by cyclical administration and uses thereof
|
|
HRP20180706T1
(hr)
|
2009-06-24 |
2018-06-01 |
Medicago Inc. |
Kimerna gripa nalik čestici koja sadrži hemaglutinin
|
|
US8828406B2
(en)
|
2009-07-30 |
2014-09-09 |
Icahn School Of Medicine At Mount Sinai |
Influenza viruses and uses thereof
|
|
JP5463107B2
(ja)
|
2009-09-14 |
2014-04-09 |
独立行政法人国立国際医療研究センター |
新型インフルエンザを特異的に鑑別するモノクローナル抗体とそれを利用した免疫検出試薬
|
|
US20120219584A1
(en)
|
2009-10-05 |
2012-08-30 |
The United States Of America As Represented By The Secretary, Department Of Health |
Protection against pandemic and seasonal strains of influenza
|
|
JP2013060367A
(ja)
|
2010-01-15 |
2013-04-04 |
Osaka Univ |
抗インフルエンザ抗体及びインフルエンザ検出用デバイス
|
|
CN102985107A
(zh)
|
2010-01-24 |
2013-03-20 |
生物模仿公司 |
免疫性流感成分
|
|
US8298820B2
(en)
|
2010-01-26 |
2012-10-30 |
The Trustees Of The University Of Pennsylvania |
Influenza nucleic acid molecules and vaccines made therefrom
|
|
CA2790380A1
(en)
|
2010-02-18 |
2011-08-25 |
Mount Sinai School Of Medicine |
Vaccines for use in the prophylaxis and treatment of influenza virus disease
|
|
PH12012501751A1
(en)
|
2010-03-04 |
2012-11-12 |
Macrogenics Inc |
Antibodies reactive with b7-h3, immunologically active fragments thereof and uses thereof
|
|
WO2011111966A2
(en)
|
2010-03-08 |
2011-09-15 |
Celltrion, Inc. |
Human monoclonal antibodies derived from human b cells and having neutralizing activity against influenza a viruses
|
|
EP3248615A1
(en)
|
2010-03-30 |
2017-11-29 |
Mount Sinai School of Medicine of New York University |
Influenza virus vaccines and uses thereof
|
|
WO2011126370A1
(en)
|
2010-04-09 |
2011-10-13 |
Universiteit Utrecht Holding B.V. |
Recombinant multimeric influenza proteins
|
|
EP2824111B1
(en)
|
2010-04-30 |
2017-03-22 |
Alexion Pharmaceuticals, Inc. |
Anti-C5A Antibodies and Methods for Using the Antibodies
|
|
ES2739711T3
(es)
|
2010-07-22 |
2020-02-03 |
John W Schrader |
Anticuerpo de protección cruzada contra la infección por el virus de la gripe
|
|
EP2652496B1
(en)
|
2010-12-13 |
2018-01-17 |
The University of Utah Research Foundation |
Vaccine antigens that direct immunity to conserved epitopes
|
|
US8841418B2
(en)
|
2011-07-01 |
2014-09-23 |
Cellerant Therapeutics, Inc. |
Antibodies that specifically bind to TIM3
|
|
IN2014CN02114A
(https=)
*
|
2011-09-20 |
2015-05-29 |
Sinai School Medicine |
|
|
CA2857087C
(en)
|
2011-11-28 |
2021-05-25 |
Crucell Holland B.V. |
Influenza virus vaccines and uses thereof
|
|
WO2013174403A1
(en)
|
2012-05-23 |
2013-11-28 |
Ganymed Pharmaceuticals Ag |
Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
|
|
CN103665155B
(zh)
|
2012-09-14 |
2016-07-06 |
中国科学院上海生命科学研究院 |
一种抗流感病毒广谱中和性的中和分子1f2
|
|
KR101452865B1
(ko)
|
2012-09-17 |
2014-10-21 |
서울대학교산학협력단 |
신규한 ｉｐ－１０ 에피토프 및 이에 대한 항체
|
|
CA2894506C
(en)
|
2012-12-11 |
2021-08-10 |
Vib Vzw |
Anti-influenza antibody
|
|
EA201591164A1
(ru)
|
2012-12-18 |
2015-11-30 |
Икан Скул Оф Медсин Эт Маунт Синай |
Вакцины против вируса гриппа и их применение
|
|
EP2943221A1
(en)
|
2013-01-10 |
2015-11-18 |
Novartis AG |
Influenza virus immunogenic compositions and uses thereof
|
|
BR112015019909A2
(pt)
|
2013-02-22 |
2017-08-29 |
Abbvie Stemcentrx Llc |
Conjugados anticorpo-fármaco, composição farmacêutica, usos dos mesmos, e kit
|
|
HK1218511A1
(zh)
|
2013-03-13 |
2017-02-24 |
Novartis Ag |
乙型流感病毒重配
|
|
US9908930B2
(en)
|
2013-03-14 |
2018-03-06 |
Icahn School Of Medicine At Mount Sinai |
Antibodies against influenza virus hemagglutinin and uses thereof
|
|
US20140286981A1
(en)
|
2013-03-14 |
2014-09-25 |
Wisconsin Alumni Research Foundation |
Broadly reactive mosaic peptide for influenza vaccine
|
|
US11827693B2
(en)
|
2013-03-14 |
2023-11-28 |
Contrafect Corporation |
Composition and methods based on neutralizing antibodies delivered intranasally for enhanced therapeutic efficacy
|
|
US9879076B2
(en)
|
2013-03-15 |
2018-01-30 |
Ramot At Tel Aviv University Ltd. |
Methods and compositions with immune therapy for treatment of dementia
|
|
US9850297B2
(en)
|
2013-03-15 |
2017-12-26 |
Amgen Inc. |
Secreted frizzle-related protein 5 (SFRP5) binding proteins
|
|
US10022434B2
(en)
|
2013-03-15 |
2018-07-17 |
The Trustees Of The University Of Pennsylvania |
Influenza nucleic acid molecules and vaccines made therefrom
|
|
US20160311918A1
(en)
|
2013-12-16 |
2016-10-27 |
Texas Tech University System |
Anti-Ron Monoclonal Antibodies as a Cytotoxic Drug Delivery System for Targeted Cancer Therapy
|
|
PL235555B1
(pl)
|
2014-06-24 |
2020-09-07 |
Inst Biotechnologii I Antybiotykow |
Wyizolowany i oczyszczony polipeptyd hemaglutyniny (HA ) wirusa grypy H5N1, kompozycja zawierająca polipeptyd i jej zastosowanie, przeciwciało wiążące się specyficznie z polipeptydem oraz sposób otrzymywania tego polipeptydu
|
|
US10117925B2
(en)
|
2014-07-10 |
2018-11-06 |
Janssen Vaccines & Prevention B.V. |
Influenza virus vaccines and uses thereof
|
|
MY187261A
(en)
|
2014-07-10 |
2021-09-16 |
Janssen Vaccines & Prevention Bv |
Influenza virus vaccines and uses thereof
|
|
CN120137055A
(zh)
|
2014-07-17 |
2025-06-13 |
恺兴生命科技(上海)有限公司 |
靶向cld18a2的t淋巴细胞及其制备方法和应用
|
|
TWI588260B
(zh)
|
2014-09-04 |
2017-06-21 |
國立清華大學 |
重組神經胺酸酶蛋白及其應用
|
|
EP3247389A4
(en)
|
2015-01-23 |
2019-10-30 |
Icahn School of Medicine at Mount Sinai |
INFLUENZAVIRUSSCHUTZIMPFPLÄNE
|
|
JP7010473B2
(ja)
|
2015-06-04 |
2022-02-10 |
ユニバーシティ オブ サザン カリフォルニア |
Ｌｙｍ－１およびｌｙｍ－２標的化ｃａｒ細胞免疫療法
|
|
WO2016205347A1
(en)
|
2015-06-16 |
2016-12-22 |
Icahn School Of Medicine At Mount Sinai |
Influenza virus vaccines and uses thereof
|
|
HK1255234A1
(zh)
|
2015-07-16 |
2019-08-09 |
塞勒兰特治疗公司 |
经半胱氨酸取代的免疫球蛋白
|
|
CA3185706C
(en)
|
2015-08-03 |
2025-11-18 |
Novartis Ag |
METHOD FOR TREATMENT OF DISORDERS ASSOCIATED WITH FGF21
|
|
WO2017035479A1
(en)
|
2015-08-27 |
2017-03-02 |
Zimmer, Inc. |
Directional locking reverse shoulder prostheses and systems
|
|
WO2017053413A1
(en)
|
2015-09-21 |
2017-03-30 |
Oregon Health & Science University |
Vaccines intelligently produced by epitope recombination (viper) for influenza
|
|
US10063211B2
(en)
|
2016-02-03 |
2018-08-28 |
Qualcomm Incorporated |
Compact bypass and decoupling structure for millimeter-wave circuits
|
|
US10703803B2
(en)
|
2016-03-01 |
2020-07-07 |
Janssen Vaccines & Prevention B.V. |
Human neutralizing antibodies binding to influenza B neuraminidase
|
|
WO2017210445A1
(en)
|
2016-06-03 |
2017-12-07 |
Icahn School Of Medicine At Mount Sinai |
Influenza virus vaccination regimens
|
|
EP3255056A1
(en)
|
2016-06-06 |
2017-12-13 |
Commissariat À L'Énergie Atomique Et Aux Énergies Alternatives |
Method for producing self-assemblying paramyxoviral nucleocapsid-like particles and their uses
|
|
CA3023143A1
(en)
|
2016-06-15 |
2017-12-21 |
Icahn School Of Medicine At Mount Sinai |
Influenza virus hemagglutinin proteins and uses thereof
|
|
AU2017299581B2
(en)
|
2016-07-20 |
2024-05-23 |
EyePoint, Inc. |
Humanized monoclonal antibodies that target ve-ptp (hptp-β)
|
|
US20180128545A1
(en)
|
2016-11-08 |
2018-05-10 |
Berry Metal Company |
Modular furnace cooling wall
|
|
JP7132230B2
(ja)
|
2017-02-10 |
2022-09-06 |
メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ |
Ｔｒａｉｌショート抗体及び使用方法
|
|
WO2018187706A2
(en)
|
2017-04-07 |
2018-10-11 |
Icahn School Of Medicine At Mount Sinai |
Anti-influenza b virus neuraminidase antibodies and uses thereof
|
|
WO2019032463A1
(en)
|
2017-08-07 |
2019-02-14 |
Icahn School Of Medicine At Mount Sinai |
IMMUNOGENIC COMPOSITIONS COMPRISING INFLUENZA VIRUS AND AS01 CHIMERIC POLYPEPTIDES OF HEMAGGLUTININ AND USES THEREOF
|
|
EP3810634A4
(en)
|
2018-06-21 |
2022-07-27 |
Icahn School of Medicine at Mount Sinai |
Mosaic influenza virus hemagglutinin polypeptides and uses thereof
|
|
EP3959216A4
(en)
|
2019-04-24 |
2023-01-11 |
Icahn School of Medicine at Mount Sinai |
ANTI-INFLUENZA B VIRUS NEURAMINIDASE ANTIBODIES AND USES THEREOF
|
|
US20220249652A1
(en)
|
2019-06-26 |
2022-08-11 |
Icahn School Of Medicine At Mount Sinai |
Influenza virus neuraminidase and uses thereof
|
|
WO2021081120A1
(en)
|
2019-10-22 |
2021-04-29 |
Icahn School Of Medicine At Mount Sinai |
Recombinant neuraminidase and uses thereof
|
|
WO2021150874A1
(en)
|
2020-01-24 |
2021-07-29 |
Wisconsin Alumni Research Foundation (Warf) |
Recombinant influenza viruses with stabilized na
|
|
CA3245262A1
(en)
|
2022-03-01 |
2023-09-07 |
Dynavax Technologies Corporation |
Immunogenic compositions comprising a recombinant neuraminidase and a CPG oligonucleotide adjuvant, and their uses
|